Abstract | BACKGROUND:
Thyroid transcription factor 1 (TTF-1) is expressed in a proportion of carcinomas derived from follicular thyroid cells and respiratory epithelium. Immunohistochemical detection of this protein was shown previously to be a helpful aid in tumour diagnosis, specifically in deciding whether a tumour is primary to the lung/thyroid gland or metastatic. Recently, TTF-1 expression was also observed in certain areas of postnatal brain. AIM/METHOD: RESULTS: All the tumours were negative for TTF-1 except for two ependymomas of the third ventricle. CONCLUSIONS: The expression of TTF-1 in brain tumours appears to be site specific rather than associated with tumour dedifferentiation. The presented expression of TTF-1 protein in certain primary brain tumours should be taken into consideration when interpreting the immunohistochemical staining of brain tumours of uncertain primary site.
|
Authors | J Zamecnik, M Chanova, R Kodet |
Journal | Journal of clinical pathology
(J Clin Pathol)
Vol. 57
Issue 10
Pg. 1111-3
(Oct 2004)
ISSN: 0021-9746 [Print] England |
PMID | 15452173
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers, Tumor
- NKX2-1 protein, human
- Nuclear Proteins
- Thyroid Nuclear Factor 1
- Transcription Factors
|
Topics |
- Biomarkers, Tumor
(analysis)
- Brain Neoplasms
(chemistry)
- Child
- Child, Preschool
- Ependymoma
(chemistry)
- Female
- Glioblastoma
(chemistry)
- Humans
- Immunohistochemistry
(methods)
- Male
- Medulloblastoma
(chemistry)
- Nuclear Proteins
(analysis)
- Pilot Projects
- Thyroid Nuclear Factor 1
- Transcription Factors
(analysis)
|